D. E. Shaw & Co., Inc. - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 55 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$9,000
-43.8%
13,010
-2.3%
0.00%
Q4 2015$16,000
-81.2%
13,310
-63.4%
0.00%
Q2 2015$85,000
-17.5%
36,374
-24.0%
0.00%
Q1 2015$103,000
-68.3%
47,860
-66.3%
0.00%
Q4 2014$325,000
+72.9%
142,119
+102.0%
0.00%
Q3 2014$188,000
+4.4%
70,371
+45.8%
0.00%
Q2 2014$180,000
+83.7%
48,251
+380.3%
0.00%
Q2 2013$98,00010,0450.00%
Other shareholders

There were no reported owners of ONCOGENEX PHARMACEUTICALS IN in Q4 2015.

NameSharesValueWeighting ↓
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders